Biological Activities of Lasso Peptides and Structure–Activity Relationships - Lasso Peptides: Bacterial Strategies to Make and Maintain Bioactive Entangled Scaffolds - page 67

Drucker DJ (2001) Minireview: the glucagon-like peptides. Endocrinology 142(2):521-527.
doi:10.1210/endo.142.2.7983
Ducancel F (2005) Endothelin-like peptides. Cell Mol Life Sci 62(23):2828-2839. doi:10.1007/
s00018-005-5286-x
Ducasse R, Li Y, Blond A, Zirah S, Lescop E, Goulard C, Guittet E, Pernodet JL, Rebuffat S
(2012a) Sviceucin, a lasso peptide from Streptomyces sviceus: isolation and structure analysis.
J Pep Sci 18 (Supp. 1):67-68
Ducasse R, Yan K-P, Goulard C, Blond A, Li Y, Lescop E, Guittet E, Rebuffat S, Zirah S (2012b)
Sequence determinants governing the topology and biological activity of a lasso peptide, mi-
crocin J25. ChemBioChem 13(3):371-380
Duda T (2010) Atrial natriuretic factor-receptor guanylate cyclase signal transduction mechanism.
Mol Cell Biochem 334(1-2):37-51. doi:10.1007/s11010-009-0335-7
Dupuy F, Morero R (2011) Microcin J25 membrane interaction: selectivity toward gel phase. Bio-
chim Biophys Acta 1808(6):1764-1771. doi:10.1016/j.bbamem.2011.02.018
Dupuy FG, Chirou MV, de Arcuri BF, Minahk CJ, Morero RD (2009) Proton motive force dis-
sipation precludes interaction of microcin J25 with RNA polymerase, but enhances reactive
oxygen species overproduction. Biochim Biophys Acta 1790(10):1307-1313. doi:10.1016/j.
bbagen.2009.07.006
Esumi Y, Suzuki Y, Itoh Y, Uramoto M, Kimura K, Goto M, Yoshihama M, Ichikawa T (2002) Pro-
peptin, a new inhibitor of prolyl endopeptidase produced by Microbispora II. Determination of
chemical structure. J Antibiot 55(3):296-300
Fagan KA, McMurtry IF, Rodman DM (2001) Role of endothelin-1 in lung disease. Respir Res
2(2):90-101
Feighery LM, Cochrane SW, Quinn T, Baird AW, O'Toole D, Owens SE, O'Donoghue D, Mrsny
RJ, Brayden DJ (2008) Myosin light chain kinase inhibition: correction of increased intestinal
epithelial permeability in vitro. Pharm Res 25(6):1377-1386. doi:10.1007/s11095-007-9527-6
Ferguson AD, Braun V, Fiedler HP, Coulton JW, Diederichs K, Welte W (2000) Crystal structure
of the antibiotic albomycin in complex with the outer membrane transporter FhuA. Protein Sci
9(5):956-963. doi:10.1110/ps.9.5.956
Ferguson AD, Kodding J, Walker G, Bos C, Coulton JW, Diederichs K, Braun V, Welte W (2001)
Active transport of an antibiotic rifamycin derivative by the outer-membrane protein FhuA.
Structure 9(8):707-716
Flayhan A, Wien F, Paternostre M, Boulanger P, Breyton C (2012) New insights into pb5, the re-
ceptor binding protein of bacteriophage T5, and its interaction with its Escherichia coli recep-
tor FhuA. Biochimie 94(9):1982-1989. doi:10.1016/j.biochi.2012.05.021
Floss HG, Yu TW (2005) Rifamycin-mode of action, resistance, and biosynthesis. Chem Rev
105(2):621-632. doi:10.1021/cr030112j
Frechet D, Guitton JD, Herman F, Faucher D, Helynck G, Monegier du Sorbier B, Ridoux JP,
James-Surcouf E, Vuilhorgne M (1994) Solution structure of RP 71955, a new 21 amino acid
tricyclic peptide active against HIV-1 virus. Biochemistry 33 (1):42-50
Fuller F, Porter JG, Arfsten AE, Miller J, Schilling JW, Scarborough RM, Lewicki JA, Schenk DB
(1988) Atrial natriuretic peptide clearance receptor. Complete sequence and functional expres-
sion of cDNA clones. J Biol Chem 263(19):9395-9401
Fulop V, Bocskei Z, Polgar L (1998) Prolyl oligopeptidase: an unusual beta-propeller domain
regulates proteolysis. Cell 94(2):161-170
Funk OF, Kettmann V, Drimal J, Langer T (2004) Chemical function based pharmacophore
generation of endothelin-A selective receptor antagonists. J Med Chem 47(11):2750-2760.
doi:10.1021/jm031041j
Gandley RE, Conrad KP, McLaughlin MK (2001) Endothelin and nitric oxide mediate reduced
myogenic reactivity of small renal arteries from pregnant rats. Am J Physiol Regul Integr
Comp Physiol 280(1):R1-R7
Garcia-Horsman JA, Mannisto PT, Venalainen JI (2007) On the role of prolyl oligopeptidase in
health and disease. Neuropeptides 41(1):1-24. doi:10.1016/j.npep.2006.10.004